Eli Lilly is suing four telemedicine companies selling compounded versions of its blockbuster obesity drug Zepbound and its diabetes treatment ... that dictate patient care, such as when Fella ...

Hims & Hers is expanding access to Eli Lilly ... kits, compounded semaglutide and branded semaglutide. The company said earlier this year it plans to sell a generic version of Novo Nordisk's ...

On Wednesday, pharmaceutical giant Eli Lilly ... and health care providers over what are widely seen as the most effective—and lucrative—drugs for treating obesity and diabetes to come on ...

said these were “important results”, and having a new pill that lowers blood sugar and weight would be “critical to future type two diabetes care”. The positive results bolster Eli Lilly ...

Eli Lilly is suing four telehealth companies selling compounded versions of the pharmaceutical giant's weight loss drug Zepbound and its diabetes treatment ... dictate patient care, such as ...

Eli Lilly said ... in people with Type 2 diabetes as the popular injectable drugs Mounjaro and Ozempic, according to results of a clinical trial announced by Eli Lilly on Thursday morning.

Eli Lilly and Company is the world's most valuable Pharma thanks to tirzepatide, a groundbreaking GLP-1 weight-loss and Type 2 Diabetes drug ... Consumers and health care professionals rely ...

FILE - A sign for Eli Lilly & Co. appears outside ... The trial is one of several that Lilly is running to test the drug, called orforglipron, in diabetes, obesity and other related conditions ...